Literature DB >> 9692996

Required buried alpha-helical structure in the bilirubin UDP-glucuronosyltransferase, UGT1A1, contains a nonreplaceable phenylalanine.

M Ciotti1, J W Cho, J George, I S Owens.   

Abstract

A conserved hydrophobic region in the bilirubin-type UDP-glucuronosyltransferase isozyme was first uncovered as a consequence of a deleterious mutation in the UGT1A1 (HUG-Br1) isozyme of a Crigler-Najjar (CN) Type I patient. According to analysis by the RAOARGOS computer program, this hydrophobic region in UGT1A1 is located between residues 159-177 and defines a buried helix centered over position 169-172 with a positive factor of 1.22. Further analysis showed that the planar phenol-type UGT1A6 (HLUG P1) isoform, unlike the steroid-type UGT2B7 (UDPGTh2) isozyme, has a similar conserved hydrophobic region and that the positive factor for its buried helix is 1.14 compared to the threshold of 1.13 for such a structure. The analysis detected the typical membrane-insertion-signal sequence and a membrane-anchoring domain in each isoform. The different amino acid sequence patterns between positions 168-172 for the three types of isoforms and the deleterious mutations in this microregion (MRA) of UGT1A1 in CN-I patients are evidence of a critical and descriminating role for MRA. With the recombinant UGT1A1 enzyme and its mutants, P167G, F170del, F170L, F170I, F170V, F170A, F170Y, F170E, F171L, F171I, F171V, F171A, F171Y, or L175Q, expressed in COS-1 cells, bilirubin glucuronidating activity at both pH 6.4 and 7.6 demonstrated that Phe-170 is not replaceable, whereas Phe-171 can be replaced by Leu without any loss of activity. The less hydrophobic buried helix in the phenolic-type UGT1A6 has a Tyr/Leu at position 170/171; this isoform glucuronidated bilirubin at 1/10 the level of that by UGT1A1 with a Km (bilirubin) of 25 microM compared to that for UGT1A1 of 5. 0 microM.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9692996     DOI: 10.1021/bi980747q

Source DB:  PubMed          Journal:  Biochemistry        ISSN: 0006-2960            Impact factor:   3.162


  8 in total

1.  Modulation of the human glucuronosyltransferase UGT1A pathway by splice isoform polypeptides is mediated through protein-protein interactions.

Authors:  Judith Bellemare; Mélanie Rouleau; Mario Harvey; Chantal Guillemette
Journal:  J Biol Chem       Date:  2009-12-08       Impact factor: 5.157

2.  Obstetric Obesity is Associated with Neonatal Hyperbilirubinemia with High Prevalence in Native Hawaiians and Pacific Island Women.

Authors:  Luc Ra Rougée; Shogo J Miyagi; Abby C Collier
Journal:  Hawaii J Med Public Health       Date:  2016-12

3.  Post-transcriptional Regulation of UGT2B10 Hepatic Expression and Activity by Alternative Splicing.

Authors:  Adrien Labriet; Eric P Allain; Michèle Rouleau; Yannick Audet-Delage; Lyne Villeneuve; Chantal Guillemette
Journal:  Drug Metab Dispos       Date:  2018-02-09       Impact factor: 3.922

4.  Role of cysteine residues in the function of human UDP glucuronosyltransferase isoform 1A1 (UGT1A1).

Authors:  Siddhartha S Ghosh; Yang Lu; Sung W Lee; Xia Wang; Chandan Guha; Jayanta Roy-Chowdhury; Namita Roy-Chowdhury
Journal:  Biochem J       Date:  2005-12-15       Impact factor: 3.857

5.  The development of UDP-glucuronosyltransferases 1A1 and 1A6 in the pediatric liver.

Authors:  Shogo J Miyagi; Abby C Collier
Journal:  Drug Metab Dispos       Date:  2011-01-25       Impact factor: 3.922

6.  Bilirubin glucuronidation revisited: proper assay conditions to estimate enzyme kinetics with recombinant UGT1A1.

Authors:  Jin Zhou; Timothy S Tracy; Rory P Remmel
Journal:  Drug Metab Dispos       Date:  2010-07-28       Impact factor: 3.922

Review 7.  The crystal structure of human UDP-glucuronosyltransferase 2B7 C-terminal end is the first mammalian UGT target to be revealed: the significance for human UGTs from both the 1A and 2B families.

Authors:  Anna Radominska-Pandya; Stacie M Bratton; Matthew R Redinbo; Michael J Miley
Journal:  Drug Metab Rev       Date:  2010-02       Impact factor: 4.518

8.  Identification of Novel UGT1A1 Variants Including UGT1A1 454C>A through the Genotyping of Healthy Participants of the HPTN 077 Study.

Authors:  Herana Kamal Seneviratne; Allyson N Hamlin; Sue Li; Beatriz Grinsztejn; Halima Dawood; Albert Y Liu; Irene Kuo; Mina C Hosseinipour; Ravindre Panchia; Leslie Cottle; Gordon Chau; Adeola Adeyeye; Alex R Rinehart; Marybeth McCauley; Joseph S Eron; Myron S Cohen; Raphael J Landovitz; Craig W Hendrix; Namandjé N Bumpus
Journal:  ACS Pharmacol Transl Sci       Date:  2021-01-21
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.